The Difference Between Leukemia And Lymphoma

There is some general confusion about the similarities and differences between leukemia and lymphoma, the two main so-called blood cancers. As blood cancers, they are set apart from the other broad category of cancer, solid tumor cancers. However, this is misleading, since it is possible to develop tumors in lymphoma.

The best place to go for an answer to the question of what the difference between leukemia and lymphoma is the American Joint Committee on Cancer, or AJCC. This oversight body annually publishes the standards to be applied in staging every type of cancer in the United States, and its influence typically reaches well beyond the US.

The Cancer Staging Handbook

According to the AJCC's most recent publication (the seventh edition of the Cancer Staging Handbook), any cancer that affects the lymphoid cells—lymphoblast, lymphocyte, follicle center cell, immunoblast, plasma cell—should first be described as a Lymphoid Neoplasm. From there, the question on the difference between leukemia and lymphoma becomes one of disease presentation.

  • If the disease only tends to affect circulating cells, it is considered a leukemia.
  • If the disease tends to produce tumor masses, it is considered a lymphoma.
  • If the disease presents both in the circulating cells and in a tumor mass, it is considered a lymphoma/leukemia.

The reason for this is because emerging research suggests there may not be a difference between leukemia and lymphoma; rather, they may be the same diseases in different stages. A good example is in chronic lymphocytic leukemia/small lymphocytic lymphoma (SLL/CLL), which had been considered different diseases but are now considered the same disease.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap